• Aucun résultat trouvé

Developing clinically useful risk stratification models

N/A
N/A
Protected

Academic year: 2021

Partager "Developing clinically useful risk stratification models"

Copied!
110
0
0

Texte intégral

Loading

Figure

Figure 1-2: AS of increasing severity [42].
Figure 2-1: Schematic of the BLR algorithm. The dataset is first partitioned into
Table 2.1: Features selected by the bootstrap lasso. GRACE = Global Registry of Acute Coronary Events; IV = intravenous.
Figure 2-2: RLR Performance on the Development Set. AUCs and six-month hazard ratios in the overall (a,b) and low-risk (GRACE < 87) subset (c,d) of the development set
+7

Références

Documents relatifs

Le bas de cette silhouette semble être transparent : on distingue derrière la silhouette un parapet en pierres de taille, il semble être peint avec un réalisme méticuleux, en effet,

An industriell gefertigten Spanplatten und MDF wurden bei Variation der Holzfeuchte der E-Modul bei Zugbelastung in Plattenebene, die Poissonsche Konstante µ12, die Zugfes-

m is a discrete variable which takes values in [1, ` − 1 − θ] (this is the number of times it would be possible to cross the threshold process)... To see that this fixed

Abbreviations: BNP = Brain Natriuretic Peptide CAD = Coronary Artery Disease CMR = Cardiac Magnetic Resonance Imaging ECG = Electrocardiography ECV = Extracellular Volume Fraction EMB

► Point- of- care ultrasonography for risk stratification of non- critical COVID-19 patients on admission (POCUSCO) is a prospective cohort study aimed to assess the value of

and colleagues proposed Ang-2 as a possible prognostic biomarker for OS at diagnosis, based on a pioneering study performed in 34 patients treated with bevacizumab

We show that the Risk Map can be used to validate market, credit, operational, or systemic risk estimates (VaR, stressed VaR, expected shortfall, and CoVaR) or to assess the

The GPLTR model, taking into account F8 mutation risk, family history of inhibitors and product type, distinguishes two groups of patients: a high-risk group for